| Literature DB >> 36042649 |
Yunjia Cai1, Linan Ren, Xinming Liu, Chen Li, Xiaokun Gang, Guixia Wang.
Abstract
RATIONALE: Thyroid storm (TS) is a rare life-threatening hypermetabolic thyrotoxicosis with an incidence of 0.57-0.76/100,000. The coexistence of TS and acute cerebral infarction is rare. Previous studies have shown that hyperthyroidism complicated by cerebral infarction mainly occurs in the intracranial basal ganglia; however, there are no reports of corpus callosum infarction. We report a case of TS complicated by cerebral infarction of the corpus callosum at our hospital. PATIENT CONCERNS: A 31-year-old male patient with a history of hyperthyroidism was admitted to the hospital because of fatigue, palpitations, fever, and profuse sweating accompanied by a mild decrease in the muscle strength of the left limb. Diagnosis of a TS was confirmed by the laboratory test results. The patient's clinical symptoms gradually improved after treatment. However, his left limb muscle strength progressively decreased, and the bilateral pathological signs were positive at the same time. Magnetic resonance imaging (MRI) of the head revealed acute cerebral infarction of the corpus callosum and pons. DIAGNOSIS: The diagnosis was thyroid strom with acute cerebral infarction of the corpus callosum and pons and severe stenosis or occlusion of the basilar artery.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36042649 PMCID: PMC9410692 DOI: 10.1097/MD.0000000000030318
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Laboratory date of the proband.
| Variable | Test value | Reference range |
|---|---|---|
| Thyroid function | ||
| TSH (uIU/ml) |
| 0.35–4.94 |
| FT3 (pmol/L) |
| 2.43–6.01 |
| FT4 (pmol/L) |
| 9.01–19.05 |
| Tg-Ab (IU/mL) |
| 0–4.11 |
| TPO-Ab (IU/mL) |
| 0–5.61 |
| TR-Ab (IU/L) |
| 0–1.75 |
| blood gas | ||
| pH | 7.44 | 7.35–7.45 |
| pCO2 (mmHg) | 37 | 35–48 |
| pO2 (mmHg) |
| 83–108 |
| HCO3− (mmol/L) |
| 18.0–23.0 |
| BE (mmol/L) | 1.1 | −2.0–3.0 |
| SpO2 (%) |
| 95–98 |
| BNP(pg/ml) |
| 0–125 |
| ESR(mm/1h) |
| 0–15 |
| HbA1c (%) | 5.7 | 4.0–6.0 |
| Homocysteine (umol/L) |
| 0–15 |
| Urinary iodine (ug/L) |
| 100–300 |
BE = base excess, BNP = pro-B-type natriuretic peptide, ESR = erythrocyte sedimentation rate, FT3 = free triiodothyronine, FT4 = free thyrocine, HbA1c = glycated haemoglobin, HCO3− = hydrogen carbonate, pCO2 = partial pressure of carbon dioxide, pO2 = partial pressure of oxygen, SpO2 = Oxygen saturation, Tg-Ab = Thyroglobulin antibody, TPO-Ab = thyroid peroxidase antibodies, TR-Ab = thyrotropin receptor antibodies, TSH = thyroid stimulating hormone.
Figure 1.2021-11-03 Computed tomography of the head revealed suspicious hypodense shadows in the pons and corpus callosum.
Figure 2.2021-11-11 The head MRI scan and diffusion examination revealed an acute and subacute lacunar infarction of the corpus callosum and pons and multiple lacunar cerebral infarctions in the brain.
Figure 3.2021-11-15 The basilar artery and bilateral vertebral arteries were partially visualized but not shown locally using magnetic resonance angiography (MRA). The proximal end of the right anterior cerebral artery A2 segment was slightly visualized in the bilateral embryonic posterior cerebral arteries.
Summary of cases of thyroid storm complicated by acute cerebral infarction.
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |
|---|---|---|---|---|---|
| Sex | F | F | M | F | M |
| Age (y) | 62 | 49 | 63 | 43 | 31 |
| Course of hyperthyroidism (mo) | 0 | 1 | 0 | NA | 24 |
| MRI findings | Right cerebellum | Precentral gyrus, postcentral gyrus, left frontal and posterior lobes, right parietal lobes | Posterior segment of right middle cerebral artery | Bilateral frontal and right temporal lobes | Corpus callosum and pons |
| Nervous system symptoms | Headache, dizziness, nausea | Quadriplegia | Left-sided hemiplegia and dysarthria | Quadriplegia and dysarthria | Left-sided hemiplegia and dysarthria |
| Atrial fibrillation | Y | N | Y | N | N |
| Thyroid function at the time of stroke (reference ranges are in parentheses) | FT3 2.90 pg/mL (1.71–3.71) | FT3 8.10 pg/dL (2–4.48) | FT3 348 ng/dL (76–181) | FT3 > 8.0 ng/mL (0.77–1.81) | FT3 > 30.72 pmol/L(2.43–6.01) |
| FT4 2.92 ng/dL (0.70–1.48) | FT4 4.41 ng/dL (0.84–1.70) | FT4 5.5 ng/dL (0.6–1.6) | FT4 9.47 pmol/L (11.4–22.6) | FT4 > 64.35 pmol/L (9.01–19.05) | |
| TSH < 0.01 uIU/ml | TSH < 0.005 mIU/L (0.5–5) | TSH < 0.01 uIU/ml (0.35–5.5) | TSH < 0.01 uIU/ml (0.55–4.78) | TSH < 0.0025 uIU/ml (0.35–4.94) | |
| Anti-thyroid medications | Thiamazole | Thiamazole | Propylthiouracil | Thiamazole | Propylthiouracil |
| Medication adherence | Good | Good | Good | Good | Good |
| Prognosis | Recovery | Recovery | Recovery | Recovery | Recovery |
| BWPS score | 110 | 85 | NA | 85 | 80 |
| Reference |
[ |
[ |
[ |
[ | Present case |
BWPS = Burch–Wartofsky scoring scale, F = female, M = male, MRI = magnetic resonance imaging, N = no, NA = not applicable, Y = yes.